Drug Trial Radar · NCT04039022
Open-Label Safety Study of AXS-05 in Subjects With Depression
Last checked: Nov 19, 2026Latest source record: Oct 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
876
Actual
Start
Jul 8, 2019
Primary completion
Oct 23, 2020
Study completion Oct 23, 2020
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 31, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label, long-term, safety study of AXS-05 in patients with major depressive disorder (MDD), including treatment resistant depression.
Conditions
- Major Depressive Disorder
- Treatment Resistant Depression
- Depression
Interventions
AXS-05 (dextromethorphan and bupropion) oral tabletsDrug
Oral tablets, taken twice daily for up to 12 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent AEs (TEAEs) Following Dosing With AXS-05Time frame: Up to 12 months
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Phoenix, Arizona
Clinical Research Site
Little Rock, Arkansas
Clinical Research Site
Bellflower, California
Clinical Research Site
Beverly Hills, California
Clinical Research Site
Culver City, California
Clinical Research Site
Garden Grove, California
Clinical Research Site
Oakland, California
Clinical Research Site
Oceanside, California
Clinical Research Site
Panorama City, California
Clinical Research Site
Redlands, California
Clinical Research Site
San Diego, California
Clinical Research Site
Sherman Oaks, California
Clinical Research Site
Upland, California
Clinical Research Site
Cromwell, Connecticut
Clinical Research Site
Coral Springs, Florida
Clinical Research Site
Hialeah, Florida
Clinical Research Site
Hollywood, Florida
Clinical Research Site
Jacksonville, Florida
Clinical Research Site
Lauderhill, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
North Miami, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Atlanta, Georgia
Clinical Research Site
Atlanta, Georgia
Clinical Research Site
Boise, Idaho
Clinical Research Site
Chicago, Illinois
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Berlin, New Jersey
Clinical Research Site
Cherry Hill, New Jersey
Clinical Research Site
Toms River, New Jersey
Clinical Research Site
Jamaica, New York
Clinical Research Site
Rochester, New York
Clinical Research Site
Staten Island, New York
Clinical Research Site
Hickory, North Carolina
Clinical Research Site
Raleigh, North Carolina
Clinical Research Site
Cincinnati, Ohio
Clinical Research Site
Cincinnati, Ohio
Clinical Research Site
Middleburg Heights, Ohio
Clinical Research Site
Oklahoma City, Oklahoma
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.